Subscribe now

Letter: Benign cannabis

Published 30 November 2002

From Paul Weidler

I am distressed once again to read an article that compares the effects of smoking cannabis to the effects of smoking tobacco, without exploring the alternatives to smoking (New Scientist online news, 13 November). The brief mention given to Corporate Pharma’s smoking alternatives such as under-the-tongue spray (very high-tech, very profitable) completely ignores one alternative that is enjoying increasing popularity.

That is to deliver cannabis via a simple vaporiser. This completely mitigates the harmful effects of carbon monoxide, tar and benzene, while delivering the healthful benefits of THC and other cannabanoids.

Your article also fails to ask the obvious question of why cannabis is typically held in the lungs longer than tobacco. I suspect that if cigarettes cost $5 each and were illegal, nicotine addicts would turn themselves blue in the face as their lungs gleaned every last molecule of drug from the smoke.

Felton, California, US

Issue no. 2371 published 30 November 2002

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop